0
Article Tier 2 Human Health Effects Sign in to save

Elevated blood microplastics and their potential association with Parkinson’s disease

Journal of Hazardous Materials 2025 1 citation

AI summary Read the abstract

Researchers collected blood samples from 21 Parkinson's disease patients and 12 healthy controls and found that patients with Parkinson's had significantly higher levels of microplastics in their blood. The Parkinson's patients also reported more frequent use of disposable plastic products and bottled water, suggesting greater environmental exposure. The study provides early evidence of a potential association between blood microplastic levels and Parkinson's disease, though further research is needed to understand any causal relationship.

Body Systems
Models
Study Type In vitro

Microplastic (MP) contamination in human blood and its potential link to Parkinson's disease (PD) remain poorly understood. In this study, we collected whole blood samples from 21 PD patients and 12 age- and sex-matched healthy controls under strict anticontamination protocols. A lifestyle questionnaire was administered to assess MP exposure-related habits, revealing that PD patients reported more frequent use of disposable plastic products and bottled water consumption, suggesting greater environmental exposure. Pyrolysis-gas chromatography-mass spectrometry (Py-GC/MS), laser direct infrared imaging (LDIR) and scanning electron microscopy (SEM) were used to quantify and characterize the MPs. Five polymer types-polyethylene (PE), polystyrene (PS), polyvinyl chloride (PVC), polypropylene (PP) and nylon-66 (PA66)-were detected in the sample. The total MP burden was significantly greater in PD patients than in controls (21.36 ± 8.42 vs. 13.56 ± 5.92 μg/g; p < 0.01), with the greatest increases observed for PVC (1.49-fold), PP (2.74-fold) and PA66 (6.62-fold), whereas the PE and PS levels were not significantly different. LDIR and SEM analyses revealed diverse particle morphologies, with most polymers appearing as granular particles. In vitro assays further revealed that PVC and PP microplastics induced dopaminergic neuron apoptosis and increased the level of phosphorylated α-synuclein (p-α-syn), providing support for their potential neurotoxicity. Together, these findings indicate elevated blood MP levels in PD patients and offer preliminary evidence linking polymer exposure with PD-related neuronal vulnerability.

More Papers Like This

Article Tier 2

Microplastic Exposure and the of Parkinson’s Disease

AI summary Read the abstract

This review examines evidence linking microplastic exposure to Parkinson's disease pathology, noting that animal studies show microplastics can decrease dopaminergic neurons and impair motor function through mechanisms resembling the disease's progression.

Article Tier 2

Plastamination: A Rising Concern for Parkinson's Disease

AI summary Read the abstract

This paper examined the potential link between widespread plastic pollution and the rising incidence of Parkinson's disease, which is growing faster than expected based on aging populations alone. Researchers highlighted how microplastics can cross the blood-brain barrier and may trigger neuroinflammation and oxidative stress associated with neurodegeneration. The study suggests that the environmental accumulation of plastic waste, termed 'plastamination,' deserves serious investigation as a possible contributing factor to neurological conditions.

Article Tier 2

Plastamination in Human Brain: The Possible Role of Microplastics in Neuroinflammation and Parkinson’s Disease

AI summary Read the abstract

Tiny plastic particles from our environment can travel through the body and cross into the brain, where research suggests they may trigger inflammation and damage that's linked to Parkinson's disease. This review pulls together existing studies to show how these plastic particles might contribute to protein clumping in the brain similar to what's seen in Parkinson's patients, though scientists stress this connection is still being investigated and more research is needed. Still, it's a reminder that reducing plastic exposure in daily life (from food packaging, water bottles, and other sources) may be worth considering for long-term brain health.

Article Tier 2

Micro-nanoplastics and Parkinson’s disease: evidence and perspectives

AI summary Read the abstract

Researchers reviewed growing evidence linking micro- and nanoplastic exposure to Parkinson's disease, a degenerative brain condition. Lab studies suggest these particles may accelerate disease by promoting the misfolding of a key brain protein (alpha-synuclein), triggering inflammation, and damaging mitochondria — though large-scale human studies are still needed to establish causation and define safe exposure thresholds.

Article Tier 2

Nanoplastics cause an increased risk of Parkinson’s disease compared to microplastics at environmental exposure levels

AI summary Read the abstract

Mice that breathed in tiny nanoplastic particles for 16 weeks showed more brain changes linked to Parkinson's disease, such as nerve cell damage and inflammation, than mice exposed to larger microplastic particles. Behavioral problems were also greater in the nanoplastic group, even though the amount reaching the brain was very small.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper